Episode notes
If you’re dismissing psychedelics in pharma, think again. Stephanie Sirota and Connor Williams discuss overcoming stigma and regulatory challenges, and the results of a recent clinical trial that could signal a new era for mental health care.
PODCAST TEAM
Producer: Devon Leaver
Editor: Dominique Guerra
Featuring: Connor Williams, Senior Researcher at RTW Investments, moderated by Stephanie A. Sirota, Partner and Chief Business Officer at RTW Investments.
Stay tuned for a deep dive into psychedelics with the CEO of GH Research, Dr. Velichka (Villy) Valcheva, moderated by Connor Williams.
FOLLOW US
Love our podcast? Follow us on LinkedIn at
Keywords
life scienceshealthcare investingbiotechpsychedelics